Header Logo

Connection

SETH LERNER to Oncolytic Virotherapy

Back to Details
This is a "connection" page, showing publications SETH LERNER has written about Oncolytic Virotherapy.
SETH LERNER
Connection Strength
0.095
Oncolytic Virotherapy
  1. A first in human phase 1 study of CG0070, a GM-CSF expressing oncolytic adenovirus, for the treatment of nonmuscle invasive bladder cancer. J Urol. 2012 Dec; 188(6):2391-7.
    View in: PubMed
    Score: 0.095
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.